Rahul Polineni, M.D.
Medical oncologist Rahul Polineni, M.D., practices a philosophy of care that matches perfectly with City of Hope: He believes in treating the whole person and not just the disease, including physical, emotional, social and spiritual aspects of illness. He enjoys helping patients during some of the most challenging and vulnerable times of their lives, in addition to the constant learning and intellectual challenge required to treat cancer.
Before joining City of Hope in 2022, Dr. Polineni was a clinical assistant professor at UCLA and an attending physician in oncology/hematology at Kern Medical in Bakersfield, California. Between his residency and his fellowship, he worked for several years as an academic hospitalist, first at Danbury Hospital in Connecticut and then at Montefiore Medical Center in New York City. As a researcher, Dr. Polineni has authored almost a dozen peer-reviewed case studies and research publications.
- 2022-present, Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Corona, CA
- 2020-2022, Clinical Assistant Professor, David Geffen School of Medicine at UCLA, Los Angeles, CA
- 2018-2022, Attending Physician, Division of Hematology/Oncology, Kern Medical, Bakersfield, CA
- 2010-2015, Academic Hospitalist, Montefiore Medical Center, Bronx, NY
- 2009-2010, Academic Hospitalist, Danbury Hospital, Danbury, CT
- 2003-2006, Staff Grade in Medical Emergency Unit, Broomfield Hospital, Chelmsford, Essex, UK
- 2019, American Board of Internal Medicine, Hematology, Medical Oncology
- 2009, American Board of Internal Medicine, General Internal Medicine
- 1995-2001, Doctor of Medicine, Patil Medical College, Bijapur, India
- 2015-2018, Fellowship in Hematology/Oncology, Mount Sinai Hospital/Icahn School of Medicine, New York, NY
- 2006-2009, Residency in Internal Medicine, Montefiore Medical Center/Albert Einstein, Bronx, NY
- 2015-present, Association of Clinical Oncology
- 2006-present, American College of Physicians
- 2001-present, Indian Medical Association
- Bhagat TD, Zhou L, Sokol L, Kessel R, Caceres G, Gundabolu K, Tamari R, Gordon S, Mantzaris I, Jodlowski T, Yu Y, Jing X, Polineni R, et al. miR-21 Mediates Hematopoietic Suppression in MDS by Activating TGF-β signaling. Blood. 2013 Apr 11;121(15):2875-81. Doi: 10.1182/blood-2011-12-397067. Epub 2013 Feb 6. PMID: 23390194.
- Shrivastava MS, Hussain Z, Giricz O, shenoy N, Polineni R, et al. Targeting Chemokine Pathways in Esophageal Adenocarcinoma. Cell Cycle. Nov 14 2014. 2014;13(21):3320-7. Doi: 10.4161/15384101.2014.968426. PMID: 25485576. Nov 14, 2014.
- Goel S, Negassa A, Khot A, Goyal D, Guo S, Nandikolla A, Bakirhan K, Polineni R, et al. Comparative Effectiveness Research: The Impact of Biologic Agents in Ethnic Minorities With Metastatic Colorectal Cancer. 2017 Dec;16(4):286-292. Doi:10.1016/j.clcc.2017.03.004. Epub 2017 Mar 14. PMID: 28412139
- Kaner JD, Thibaud S, Jasra S, Wang Y, Janakiram M, Sharma A, Sridharan A, Elias H, Polineni R, et al. HIV Portends a Poor Prognosis in Myelodysplastic Syndromes. Leuk Lymphoma. 2019 Jul 8:1-7. Doi: 10.1080/10428194.2019.1633631. (Epub ahead of print). PMID: 31282240
- Delgado B, Moosavi L, Rangel E, Stull W, Polineni RD, et al. An Unusual Presentation of Spinal Cell Glioblastoma in a 21-Year-Old Female. J Investig. Med High Impact Case Rep. 2019 Jan-Dec;7:2324709629868255, PMID:31394931. Aug 9, 2019.
- Agarwal A, Polineni R, Hussein Z, Vigoda I, Bhagat TD, Bhattacharyya S, Maitra A, Verma A. Role of epigenetic alterations in the pathogenesis of Barrett’s Esophagus and Esophageal Adenocarcinoma. Int J Clin Exp Pathol. 2012;5(5):382-96. Epub 2012 May 23. PMID:22808291